Janssen Unopposed To MDL For Elmiron Eye Injuries But Wants Cases Reined In
WASHINGTON, D.C. — Janssen Pharmaceuticals Inc. on Oct. 15 told a judicial panel it does not oppose creation of a multidistrict litigation for Elmiron eye injury cases but suggested assigning the...To view the full article, register now.
Already a subscriber? Click here to view full article